Showing 1 - 8 results of 8 for search 'Yuxiang MA', query time: 0.01s Refine Results
  1. 1
    Traffic scheduling method based on segment routing in software-defined networking

    Traffic scheduling method based on segment routing in software-defined networking by Qian DONG, Jun LI, Yuxiang MA, Shujun HAN

    Published 2018-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Traffic scheduling method based on segment routing in software-defined networking

    Traffic scheduling method based on segment routing in software-defined networking by Qian DONG, Jun LI, Yuxiang MA, Shujun HAN

    Published 2018-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Retrieval of Three-Dimensional Wave Surfaces from X-Band Marine Radar Images Utilizing Enhanced Pix2Pix Model

    Retrieval of Three-Dimensional Wave Surfaces from X-Band Marine Radar Images Utilizing Enhanced Pix2Pix Model by Lingyi Hou, Xiao Wang, Bo Yang, Zhiyuan Wei, Yuwen Sun, Yuxiang Ma

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Anti-OX40 antibody BAT6026 in patients with advanced solid tumors: A multi-center phase I study

    Anti-OX40 antibody BAT6026 in patients with advanced solid tumors: A multi-center phase I study by Huaqiang Zhou, Yuxiang Ma, Yongsheng Li, Long Tang, Yubiao Guo, Gang Yuan, Ziyi Fu, Jin-Chen Yu, Li Zhang, Hongyun Zhao

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors

    Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors by Zihong Chen, Gang Chen, Yuxiang Ma, Hongyun Zhao, Jianhua Zhan, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Shaodong Hong, Ting Zhou, Wenfeng Fang, Li Zhang, Yaxiong Zhang

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Phase 1b/2 study of ADG106, a 4-1BB/CD137 agonist, in combination with toripalimab in patients with advanced solid tumors

    Phase 1b/2 study of ADG106, a 4-1BB/CD137 agonist, in combination with toripalimab in patients with advanced solid tumors by Shaoyan Lin, Yuxiang Ma, Yongsheng Wang, Yunpeng Yang, Jinhui Xue, Yan Huang, Yuanyuan Zhao, Wenfeng Fang, Shaodong Hong, Yang Zhang, Qianwen Liu, Guizhong Liu, Xiaohong She, Jiping Zha, Songmao Zheng, Yan Li, Peter Luo, Li Zhang, Hongyun Zhao

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations.

    Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations. by Wenhua Liang, Xuan Wu, Wenfeng Fang, Yuanyuan Zhao, Yunpeng Yang, Zhihuang Hu, Cong Xue, Jing Zhang, Jianwei Zhang, Yuxiang Ma, Ting Zhou, Yue Yan, Xue Hou, Tao Qin, Xiaoxiao Dinglin, Ying Tian, Peiyu Huang, Yan Huang, Hongyun Zhao, Li Zhang

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced non–small cell lung cancer

    HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced non–small cell lung cancer by Jianhua Zhan, Jinhui Xue, Lin Wu, Zhiye Zhang, Qiming Wang, Yuxiang Ma, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Wenfeng Fang, Yang Zhang, Qianwen Liu, Wen Xu, Yan Yang, Zhenming Chen, Baili Song, Danni Sun, Xia Sun, Peng Gao, Hongyun Zhao, Li Zhang

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: